单次、新辅助与辅助栓塞伽玛刀放射外科治疗动静脉畸形的比较
回顾性分析228例接受伽玛刀放射外科治疗的脑动静脉畸形患者,新辅助栓塞组29例(12.7%)、辅助栓塞组19例(8.3%)、未栓塞组180例(78.9%)。多变量Cox回归显示新辅助栓塞与伽玛刀后36个月闭塞呈显著负相关(风险比0.326,P=0.006)。作者认为新辅助或辅助栓塞伽玛刀对高危复杂血管构筑动静脉畸形有益,但伽玛刀前栓塞可能是晚期闭塞(>36个月)的负面预测因素。
要点
- 新辅助栓塞组29例(12.7%)、辅助栓塞组19例(8.3%)、未栓塞组180例(78.9%)。
- 三组在既往出血史和动脉瘤存在方面差异显著(P<.0001)。
- 新辅助栓塞与伽玛刀后36个月闭塞显著负相关(风险比0.326,P=0.006)。
核心结论
- 新辅助或辅助栓塞联合伽玛刀放射外科是治疗血管构筑高度复杂、潜伏期有出血风险的动静脉畸形的有益方法。
- 伽玛刀前栓塞可能是晚期闭塞(>36个月)的负面预测因素。
- 作者认为需更大样本量和持续随访的进一步研究来证实结论。
研究设计与样本
- 回顾性分析2007年1月至2017年12月在本机构接受伽玛刀放射外科治疗的453例动静脉畸形患者数据库。
- 最终纳入228例患者,分为新辅助栓塞组29例(12.7%)、辅助栓塞组19例(8.3%)和未栓塞组180例(78.9%)。
- 比较三组闭塞率、潜伏期出血发生率、囊肿形成和放射诱导变化,并分析预测闭塞和并发症的变量。
主要发现
- 三组在既往出血史和动脉瘤存在方面差异显著(P<.0001)。
- 多变量Cox回归分析显示新辅助栓塞与伽玛刀后36个月闭塞呈显著负相关(风险比0.326,P=0.006)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需更大样本量和持续随访的进一步研究来证实结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of intracranial arteriovenous malformations (AVMs) treatment is to prevent bleeding or subsequent hemorrhage with complete obliteration. For large, difficult-to-treat AVMs, multimodal approaches including surgery, endovascular embolization, and gamma knife radiosurgery (GKRS) are frequently used. OBJECTIVE: To analyze the outcomes of AVMs treated with single-session, neoadjuvant, and adjuvant embolization GKRS. METHODS: We retrospectively reviewed a database of 453 patients with AVMs who underwent GKRS between January 2007 and December 2017 at our facility. The obliteration rate, incidence of latent period bleeding, cyst formation, and radiation-induced changes were compared among the 3 groups, neoadjuvant-embolized, adjuvant-embolized, nonembolized group. In addition, the variables predicting AVM obliteration and complications were investigated. RESULTS: A total of 228 patients were enrolled in this study. The neoadjuvant-embolized, adjuvant-embolized, and nonembolized groups comprised 29 (12.7%), 19 (8.3%), and 180 (78.9%) patients, respectively. Significant differences were detected among the 3 groups in the history of previous hemorrhage and the presence of aneurysms ( P < .0001). Multivariate Cox regression analyses revealed a significant inverse correlation between neoadjuvant embolization and obliteration occurring 36 months after GKRS (hazard ratio, 0.326; P = .006). CONCLUSION: GKRS with either neoadjuvant or adjuvant embolization is a beneficial approach for the treatment of AVMs with highly complex angioarchitectures that are at risk for hemorrhage during the latency period. Embolization before GKRS may be a negative predictive factor for late-stage obliteration (>36 months). To confirm our conclusions, further studies involving a larger number of patients and continuous follow-up are necessary.
引用
- Kim MJ, Jung HH, Kim YB, et al. Comparison of Single-Session, Neoadjuvant, and Adjuvant Embolization Gamma Knife Radiosurgery for Arteriovenous Malformation. Neurosurgery. 2022. PMID: 36700732. doi:10.1227/neu.0000000000002308
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。